USPTO serial 79405529
ALPIONER THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 6, 2025
- Examiner
- CORWIN, KEVIN SCOTT
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ALPIONER THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
JANET G RICCIUTI
JANET G RICCIUTI JANET GILBERT RICCIUTI PC2003 Kalorama Road NWWASHINGTON, DC 20009United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in the manufacture of human pharmaceutical and vaccine products and veterinary pharmaceutical and vaccine products; Plant extracts, active ingredients and excipients, other than essential oils, used in the manufacture of human pharmaceutical and vaccine products and veterinary pharmaceutical and vaccine products; Antibodies used in the manufacture of active vaccine ingredients | ACTIVE | — |
| 005 | Pharmaceutical products, namely, pharmaceutical preparations for the diagnosis, the prevention, the monitoring and the treatment of cancers, community and hospital-acquired infections, chronic respiratory diseases, wounds healing; Pharmaceutical products, namely, antibodies and monoclonal antibodies for medical purposes; Veterinary products, namely, veterinary pharmaceutical preparations for the diagnosis, the prevention, the monitoring and the treatment of cancers, community and hospital-acquired infections, chronic respiratory diseases, wounds healing; Vaccines for human use; Vaccines for veterinary use | ACTIVE | — |
| 042 | Medical research services; scientific research for medical purposes; Research and development of vaccines and medicines | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ALPIONER THERAPEUTICS
- Other trademarks owned by ALPIONER THERAPEUTICS
- Other trademarks owned by ALPIONER THERAPEUTICS
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ALPIONER THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 19, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 2, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 2, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 25, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 5, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 5, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 2, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 7, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 6, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 6, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 18, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 18, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 12, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 25, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 25, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 25, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 25, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 15, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 30, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 30, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 28, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 27, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 9, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 9, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 3, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |